ARCHIVES

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 09 | March 7, 2008

Download PDF Visit The Full Archive

Related Articles

‘Rush To Downsize’ Is A Danger To NCI, Broder Warns In A Farewell Address

January 13, 1995

Other NCI funding opportunities listed.

July 9, 2004

News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements

January 27, 2012

Heckler Announces NCI Team Headed By Gallo Has Found Cause Of AIDS

April 27, 1984

Fox Chase Cancer Center plans $1 billion expansion that would double its size.

October 22, 2004

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005